Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...
Because aircraft personnel are routinely exposed to galactic cosmic radiation and ultraviolet radiation, they face an elevated risk for certain cancers.
The latest update is out from Scancell Holdings ( (GB:SCLP) ).
Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...
Pembrolizumab plus EVX-01, a personalized peptide-based neoantigen cancer vaccine, demonstrated the “ability to induce potent and sustained T-cell responses” among patients with previously untreated, ...
University of Queensland researchers have found that a genetic mutation that causes melanoma can lie dormant in healthy skin, ...
NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, ...
Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.
Despite declining melanoma mortality among non-Hispanic White individuals, survival disparities persist for Latino populations. A recently published qualitative study examined interviews with Latino ...
Medicenna Therapeutics Corp has announced a collaboration with Fondazione Melanoma Onlus to conduct the NEO-CYT trial, which will evaluate MDNA11, a next-generation IL-2 Superkine, as a neoadjuvant ...
A 'super vaccine' could give people immunity against cancer before the disease grows and spreads. Scientists in Massachusetts say their experimental jab prevents several aggressive cancers. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback